Phase 2 Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

TORL Biotherapeutics, LLC155 enrolled3 locationsNCT07439653

Recruiting

Phase 2

Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas

Mantle Cell LymphomaMarginal Zone LymphomaRelapsed or Refractory B-cell Non-Hodgkin Lymphoma

University of Utah27 enrolled1 locationNCT06300528